FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17462311000001107: Votrient 200mg tablets (GlaxoSmithKline UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60381501000001118 Votrient 200mg tablets (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92758501000001111 Votrient 200mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction restricted availability true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Is a Pazopanib 200mg tablets true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Is a Pazopanib 200mg tablets false Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Is a Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient Pazopanib false Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient Pazopanib hydrochloride false Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Is a Votrient true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pazopanib true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has basis of strength substance Pazopanib true Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient Pazopanib hydrochloride true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has AMP True Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start